mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.2 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.3 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.3 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.3 |
mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
CGP-082996 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.3 |